期刊文献+

高三酰甘油血症和动脉粥样硬化 被引量:2

Hypertriglyceridemia and atherosclerosis
原文传递
导出
摘要 低密度脂蛋白胆固醇增高是动脉粥样硬化和冠心病的重要危险因素,近年来大量研究结果表明高三酰甘油血症也是动脉粥样硬化和冠心病的重要危险因素。针对高三酰甘油血症的治疗可降低心血管事件的发生率。本文对三酰甘油的代谢、高三酰甘油血症和动脉粥样硬化的关系、高三酰甘油血症的治疗进展等作一简述。 It is well known that high plasma low density lipoprotein cholesterol is an important risk factor for atheroselerosis and coronary artery disease. Recently, a large amount of study showed that hypertriglyceri- demia was also the main risk factor for atherosclerosis and coronary artery disease. The treatment targeting hypertriglyceridemia may decrease the incidence of cardiovascular events. The metabolism of trigIyceride, the relation between bypertriglyceridemia and atherosclerosis, the advances of treatment for hypertriglyceridemia are reviewed in this paper.
作者 黄震华
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2015年第11期813-817,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 血脂异常 动脉粥样硬化 冠心病 心血管疾病 dyslipidemias atherosclerosis coronary disease cardiovascular diseases
  • 相关文献

参考文献30

  • 1HEGELE RA, GINSBERG HN, CHAPMAN M J, et al. On behalf of the European Atherosclerosis Society Consensus Panel. The palygenic nature of hypertriglyceridaemia: implications for definition, diagosis, and management [J]. Lancet Diabetes Endocrinal, 2014, 2(8): 655-666.
  • 2DEMIGNOT S, DEIISTEIN F, MOREL E. Triglyceride-rich lipoproteins and cytosalic lipid droplets in enterocytes: key players in intestinal physialogy and metabalic disorders[J]. Biochimie, 2014, 96: 48-55.
  • 3RASHID S, TAVORI H, BROWN PE, et al. Preprotein convertase cubtilisin kexin type 9 promotes intestinal overproduction of triglyceride- rich apalipoprotein- B lipoproteins through both LDL- receptor dependent and independent mechanisms[J]. Circulation, 2014, 130(5) : 431-441.
  • 4BOUCHOUX J, B EILSTEIN F, PAUQUAI T, et al. Theproteome of cytosalic lipid droplets isalated from differentiated Caeo-2/TC7 enterocytes reveals cell-specific characteristics[J]. Bial Cell, 2011, 103(11): 499-517.
  • 5ADIELS M, MATIKAINEN N, WESTERBACKA J, et al. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity[J]. Atherosclerosis, 2012, 222(1): 222-228.
  • 6LARSSON M, VORRSJO E, TALMUD P, et aL Apalipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets[J]. J Bial Chem, 2013, 288 (47) : 33997-34008.
  • 7JORGENSEN AB, FRIKKE-SCHMIDT R, WEST AS, et al. Genetically elevated non- fasting triglycerides and calculated remnant chalesteral as causal risk factors for myocardial infarction[J]. Eur Heart J, 2013, 34(24) : 1826-1833.
  • 8GAO Y, SHEN W, ZHANG Q, et al. Upregulation of hepatic VLDLR via PPAR cds required for the triglyceride- lowering effect of fenofibrate[J]. J Lipid Res, 2014, 55(8) : 1622-1633.
  • 9DO R, WILLER CJ, SCHMIDT EM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease[J]. Nat Genet, 2013, 45 (11 ) : 1345-1352.
  • 10BOEKHOLDT SM, ARSENAULT B J, MORA S, et al. Association of LDL chalesteral, non- HDL chalesteral, and apalipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis[J]. JAMA, 2012, 307(12) : 1302-1309.

同被引文献36

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部